IL-6 AND VEGF IN SMALL CELL LUNG CANCER PATIENTS

被引：0
|
作者：
Kulpa, J. K. [1 ]
Wojcik, E. [1 ]
Skotnicki, P. [1 ]
Tarapacz, J. [1 ]
机构：
[1] M Sklodowska Curie Mem Inst, Cracow Div, Ctr Oncol, Dept Clin Biochem, Krakow, Poland
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：4075 / 4075
页数：1
相关论文
共 50 条
  • [21] IL-6 triggers chemoimmunotherapy resistance by creating immunosuppressive tumor microenvironment in non-small cell lung cancer
    Yang, Y.
    Liu, C.
    Yang, L.
    Yang, G.
    Hao, X.
    Zhang, S.
    ANNALS OF ONCOLOGY, 2023, 34
  • [22] Interleukin-6 (IL-6) as a potential predictive marker and a desensitizer for immunotherapy response in non-small cell lung cancer
    Wang, Y.
    Liu, C.
    Yang, L.
    Xu, H.
    Sun, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1007 - S1008
  • [23] Prognostic value of serum IL-17 and VEGF levels in small cell lung cancer
    Lin, Qunying
    Xue, Lei
    Tian, Tian
    Zhang, Bo
    Guo, Lijing
    Lin, Guosheng
    Chen, Zhiwei
    Fan, Kexing
    Gu, Xiaobin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (04): : E359 - E363
  • [24] IL-6 promotes stemness of cancer stem cells and may contribute to radiation resistance of non-small cell lung cancer
    Chen, Yuhchyau
    Tsai, Ying
    Hsu, Jong-Wei
    Duan, Shan-Zhou
    Keng, Peter
    Lee, Soo Ok
    CANCER RESEARCH, 2014, 74 (19)
  • [25] FMD, VEGF, AND IL-6 IN VEDOSS PATIENTS: THE PRECOCITY OF ENDOTHELIAL DYSFUNCTION
    Bosello, S. L.
    Canestrari, G.
    Capacci, A.
    Di Giorgio, A.
    De Luca, G.
    Bocci, M.
    Parisi, F.
    Berardi, G.
    Rucco, M.
    Alivernini, S.
    Santoliquido, A.
    Ferraccioli, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 872 - 872
  • [26] TNF-α, TNF-β, IL-6, and IL-10 polymorphisms in patients with lung cancer
    Seifart, C
    Plagens, A
    Dempfle, A
    Clostermann, U
    Vogelmeier, C
    von Wichert, P
    Seifart, U
    DISEASE MARKERS, 2005, 21 (03) : 157 - 165
  • [27] Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients
    Liu, Gang
    Chen, Xiang-Ting
    Zhang, Hao
    Chen, Xin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients
    Yamaguchi, T
    Kimura, H
    Yokota, S
    Yamamoto, Y
    Hashimoto, T
    Nakagawa, M
    Ito, M
    Ogura, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (02) : 53 - 58
  • [29] Relationship between preoperative serum IL-6/VEGF and pTNM Stage in 668 colorectal cancer patients
    Nakai, Nozomu
    Takahashi, Hiroki
    Ando, Nanako
    Yanagita, Takeshi
    Maeda, Yuzo
    Hirokawa, Takahisa
    Shiga, Kazuyoshi
    Hara, Masayasu
    Matsuo, Yoichi
    Ishiguro, Hideyuki
    Takiguchi, Shuji
    CANCER SCIENCE, 2018, 109 : 546 - 546
  • [30] Serum IL-6 as a vital predictor of severe lung cancer
    An, Jian
    Gu, Qihua
    Cao, Liming
    Yang, Huaping
    Deng, Pengbo
    Hu, Chengping
    Li, Min
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 202 - 209
12345